VirExit Technologies EBITDA

What does VirExit Technologies do? VirExit Technologies, Inc. generates revenue through its branded products and services, including disinfectant cleaners, antiviral medications, personal protective equipment (PPE), and sterilization systems under the VirExit(r) and VirExit.com brands. The company targets buyers seeking protective solutions for individual, community, and local economic needs in rural and peri-urban areas globally. Its Lexian product, an Ultraviolet-C-based device, is marketed as a sterilization system for disabling viruses and bacteria through optical diffusion. The firm operates a vertical online marketplace as a primary sales and marketing platform, connecting buyers and sellers of protective products and services. This platform serves as a single source for customers requiring disinfectants, medications, PPE, and sterilization systems. VirExit(r) and VirExit.com are the key brands driving product visibility and sales across its target segments. VirExit Technologies focuses on rural and peri-urban markets worldwide, where it incubates franchise business concepts to support local economies. The company's offerings are designed to address health and safety needs, with Lexian positioned as a specialized sterilization solution. Its business model integrates product sales, franchise incubation, and an online marketplace to serve both individual and community-level demand. VirExit Technologies is one of the most popular companies on Eulerpool.